Tachyarrhythmia Absoluta – Causes and Treatment
Tachyarrhythmia absoluta is a form of atrial fibrillation characterized by a rapid, completely irregular heartbeat. It requires prompt medical evaluation and treatment.
Things worth knowing about "Tachyarrhythmia Absoluta"
Tachyarrhythmia absoluta is a form of atrial fibrillation characterized by a rapid, completely irregular heartbeat. It requires prompt medical evaluation and treatment.
What is Tachyarrhythmia Absoluta?
Tachyarrhythmia absoluta is a clinical term for atrial fibrillation (AFib) presenting with a fast and completely irregular heart rhythm. The term combines tachycardia (elevated heart rate), arrhythmia (irregular rhythm), and absoluta (absolute, meaning entirely irregular). The heart rate typically ranges from 100 to 180 beats per minute, sometimes even higher. It is the most common clinically significant cardiac arrhythmia worldwide.
Causes
Tachyarrhythmia absoluta develops when the electrical signals in the atria (upper chambers of the heart) become chaotic and uncoordinated. Common causes include:
- Coronary artery disease (narrowing of the coronary arteries)
- Arterial hypertension (high blood pressure)
- Heart valve disease, especially of the mitral valve
- Heart failure
- Hyperthyroidism (overactive thyroid gland)
- Excessive alcohol or caffeine consumption
- Electrolyte imbalances (e.g., low potassium levels)
- Inflammatory heart conditions such as myocarditis or pericarditis
- Idiopathic causes (no identifiable cause, especially in younger patients)
Symptoms
Symptoms can vary considerably depending on the severity and the presence of underlying conditions. Typical complaints include:
- Rapid heartbeat or palpitations
- Irregular pulse, which patients often notice themselves
- Shortness of breath, especially during physical activity
- Dizziness or lightheadedness
- Chest pain or a feeling of pressure in the chest
- Reduced exercise tolerance and fatigue
- In severe cases: loss of consciousness or syncope
Some individuals have no noticeable symptoms and are only diagnosed incidentally during a routine examination.
Diagnosis
The diagnosis of tachyarrhythmia absoluta is primarily established through:
- Electrocardiogram (ECG): The ECG shows a characteristic pattern with irregularly spaced RR intervals, absence of distinct P waves, and an elevated ventricular rate.
- Holter ECG (ambulatory ECG monitoring): Used to detect intermittent (paroxysmal) episodes over 24 to 48 hours.
- Echocardiography: Ultrasound imaging of the heart to assess cardiac structure and function, and to rule out atrial thrombi (blood clots).
- Blood tests: Evaluation of thyroid function, electrolytes, and inflammatory markers.
- Blood pressure measurement and clinical examination.
Treatment
Rate Control
The primary goal of treatment is often to reduce the heart rate to a normal resting range (60-100 beats per minute). Medications used include:
- Beta-blockers (e.g., metoprolol, bisoprolol)
- Calcium channel blockers (e.g., verapamil, diltiazem)
- Cardiac glycosides (e.g., digoxin, particularly in patients with heart failure)
Rhythm Control
In selected patients, restoration of normal sinus rhythm may be attempted through:
- Pharmacological cardioversion using antiarrhythmic drugs (e.g., amiodarone, flecainide)
- Electrical cardioversion: Delivery of a controlled electric shock under short general anesthesia to restore normal rhythm
- Catheter ablation: A minimally invasive procedure in which the trigger sites of atrial fibrillation are destroyed using radiofrequency energy or cryotherapy
Anticoagulation (Blood Thinners)
Because atrial fibrillation significantly increases the risk of stroke (blood clots can form in the atria and travel to the brain), most patients require anticoagulant therapy. Options include:
- Direct oral anticoagulants (DOACs) such as apixaban, rivaroxaban, or dabigatran
- Vitamin K antagonists such as warfarin or phenprocoumon
Prognosis and Course
With appropriate treatment, most patients experience a significant improvement in quality of life. The risk of stroke can be substantially reduced with consistent anticoagulation therapy. If left untreated, the condition can lead to serious complications including heart failure and stroke. Regular follow-up with a cardiologist is therefore essential.
References
- Hindricks G. et al. - 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation. European Heart Journal, 2021; 42(5): 373-498. (European Society of Cardiology)
- Fuster V. et al. - ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation. Circulation, 2006; 114(7): 700-752.
- January C.T. et al. - 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. Journal of the American College of Cardiology, 2019; 74(1): 104-132.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryFood craving
Portion control
Weight loss
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Tachyarrhythmia Absoluta-en